An FDA advisory panel tended to embrace a new gene therapy treatment from Vertex and CRISPR for sickle cell anemia on Tuesday.
CRISPR, Vertex gene editing therapy gets warm response from FDA panel
Posted in bioengineering, biotech/medical
Posted in bioengineering, biotech/medical
An FDA advisory panel tended to embrace a new gene therapy treatment from Vertex and CRISPR for sickle cell anemia on Tuesday.